K213164: Avaira Vitality (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K213164 (Avaira Vitality, cleared 2021-10-26 for CooperVision, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K213164
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK213164
Cleared Device Trade / Generic NameAvaira Vitality
FDA Applicant on FilingCooperVision, Inc.
FDA 3-Letter Product ClassificationProduct Code LPL
FDA Substantial Equivalence Decision Date2021-10-26
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for CooperCompanies across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at CooperVision, Inc., compare peer devices under FDA Product Code LPL, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.